Mir Imran

President
InCube, Inc.
Menlo Park, CA

Mr. Imran is recognized for his history as a scientist, inventor, entrepreneur and investor of medical technology companies. He is the founder and Chairman of InCube Laboratories, Inc. (http://in-cube.com ), research laboratories and business incubator for medical and technology companies. Through InCube, and prior to its establishment, he founded numerous medical and high technology companies. Mr. Imran currently serves as a Director for CardioVasc, Inc., Zonare, Inc., Intrapace, Inc., Entrack, Inc., SafeView, Inc., Bodymedia, Inc., EGeen Inc. Acumen Medical Inc., Python Medical, Inc. and Neurolinks, Inc. He was a pioneer in the development of the automatic implantable defibrillator, a device that has saved hundreds of thousands of lives, and has become a standard of care in cardiology. One of his high profile medical inventions is his EEG monitoring sensor array that John Glenn was featured as wearing in the Time Magazine story of his latest space mission. This became the core product for Physiometrix and has become a standard diagnostic tool used in neurophysiology. In 1992, Mr. Imran invented a cooled RF ablation catheter for the treatment of ventricular arrhythmias. This invention became the initial product of Cardiac Pathways, and is now widely used by cardiac electro-physiologists. In 1995, he developed a low-pressure balloon and aspirator system for use in catheter based interventions. Mr. Imran was the first to articulate the concept of distal protection during high-risk interventions. Mr. Imran?s device became the primary innovation for Percusurge, which was acquired by Medtronic in December 2000. In the medical field Mr. Imran?s interest is to develop medical devices that blur the distinction between organic and synthetic and advance patient treatment options.